The role of preeclampsia in breast cancer risk: insights from Mendelian randomization study

被引:0
|
作者
Qian, Chenfei [1 ]
Xiong, Ganwei [2 ]
Hong, Shihao [3 ]
Miao, Linzhe [1 ]
Guo, Yitao [1 ,4 ]
机构
[1] Zhejiang Hosp, Hangzhou 310013, Peoples R China
[2] First Peoples Hosp Xiushui Cty, Jiujiang 332400, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Obstet & Gynecol, Hangzhou 310016, Peoples R China
[4] Zhejiang Hosp, Dept Cardiol, Hangzhou 310013, Peoples R China
关键词
Preeclampsia; Breast cancer; Genome-wide association study; Mendelian randomization; Meta-analysis; ENDOTHELIAL-GROWTH-FACTOR; VEGF EXPRESSION; PREGNANCY; PATHOPHYSIOLOGY; ASSOCIATION; SERUM;
D O I
10.1007/s12672-025-02248-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The relationship between preeclampsia and breast cancer risk is still debated, with observational studies yielding inconsistent results. This research aims to clarify the causal link between preeclampsia and breast cancer using Mendelian randomization (MR) methods. Methods We utilized genome-wide association study (GWAS) data to identify single nucleotide polymorphisms (SNPs) that are significantly associated with preeclampsia, which served as genetic instruments. A two-sample Mendelian randomization (TSMR) approach was applied, primarily using inverse variance weighting (IVW) to assess the causal impact of preeclampsia on breast cancer risk. To strengthen our findings, a meta-analysis of IVW estimates from both discovery and validation cohorts was performed, complemented by sensitivity analyses to investigate heterogeneity and potential horizontal pleiotropy. Results In the discovery cohort, IVW analysis revealed a potential inverse relationship between preeclampsia and breast cancer risk (OR, 0.971; 95% CI, 0.947-0.996; P = 0.022). However, the validation cohort did not demonstrate a significant causal association (OR, 0.992; 95% CI, 0.975-1.008; P = 0.327). The combined meta-analysis indicated that preeclampsia might be linked to a lower risk of breast cancer (OR, 0.986; 95% CI, 0.972-0.999; P = 0.041). In subgroup analysis, preeclampsia was found to have a potential association only with estrogen receptor (ER)-negative breast cancer (OR, 0.956; 95% CI, 0.916-0.999; P = 0.043), while no significant link was observed with estrogen receptor (ER)-positive breast cancer (OR, 0.972; 95% CI, 0.945-1.000; P = 0.051). Sensitivity analyses indicated no significant heterogeneity or evidence of horizontal pleiotropy (P > 0.05). Conclusion This MR study, supported by a robust meta-analysis, suggests that preeclampsia may have a protective effect against breast cancer, especially ER-negative breast cancer. However, to firmly establish this relationship, additional prospective studies with larger populations are warranted. Moreover, further exploration of the biological mechanisms underlying this potential association is needed through both in vitro and in vivo research.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Omeprazole and risk of osteoarthritis: insights from a mendelian randomization study in the UK Biobank
    Cao, Siyang
    Wei, Yihao
    Yue, Yaohang
    Li, Guoqing
    Wang, Hongli
    Lin, Jianjing
    Wang, Qichang
    Liu, Peng
    Yu, Fei
    Xiong, Ao
    Zeng, Hui
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [32] The Role of Polyunsaturated Fatty Acids in Osteoarthritis: Insights from a Mendelian Randomization Study
    Li, Xuefei
    Lu, Zhengjie
    Qi, Yongjian
    Chen, Biao
    Li, Bin
    NUTRIENTS, 2023, 15 (22)
  • [33] Identifying therapeutic targets for breast cancer: insights from systematic Mendelian randomization analysis
    Yao, Tao
    Lin, Yun-Lu
    Wu, Yu-Qing
    Qian, Xin-Ge
    Wang, Zhe-Ning
    Qian, Sang
    Jiang, Ting
    Liu, Jing-Chen
    Fang, Luo-Xiang
    Zhen, Cheng
    Wu, Chun-Hui
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [34] Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
    Zhang, Ben
    Shu, Xiao-Ou
    Delahanty, Ryan J.
    Zeng, Chenjie
    Michailidou, Kyriaki
    Bolla, Manjeet K.
    Wang, Qin
    Dennis, Joe
    Wen, Wanqing
    Long, Jirong
    Li, Chun
    Dunning, Alison M.
    Chang-Claude, Jenny
    Shah, Mitul
    Perkins, Barbara J.
    Czene, Kamila
    Darabi, Hatef
    Eriksson, Mikael
    Bojesen, Stig E.
    Nordestgaard, Borge G.
    Nielsen, Sune F.
    Flyger, Henrik
    Lambrechts, Diether
    Neven, Patrick
    Wildiers, Hans
    Floris, Giuseppe
    Schmidt, Marjanka K.
    Rookus, Matti A.
    van den Hurk, Katja
    de Kort, Wim L. A. M.
    Couch, Fergus J.
    Olson, Janet E.
    Hallberg, Emily
    Vachon, Celine
    Rudolph, Anja
    Seibold, Petra
    Flesch-Janys, Dieter
    Peto, Julian
    dos-Santos-Silva, Isabel
    Fletcher, Olivia
    Johnson, Nichola
    Nevanlinna, Heli
    Muranen, Taru A.
    Aittomaki, Kristiina
    Blomqvist, Carl
    Li, Jingmei
    Humphreys, Keith
    Brand, Judith
    Guenel, Pascal
    Truong, Therese
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (11):
  • [35] Sleep duration and heart failure risk: Insights from a Mendelian Randomization Study
    Zeng, Lianlin
    Fu, Shasha
    Xu, Hailan
    Zhu, Lutao
    Li, Xiaomei
    Cheng, Kang
    Li, Yangan
    Hu, Kehui
    MEDICINE, 2024, 103 (37)
  • [36] Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study
    Chen, Lanlan
    Yang, Hongqun
    Li, Haitao
    He, Chang
    Yang, Liu
    Lv, Guoyue
    HEPATOLOGY, 2022, 75 (04) : 785 - 796
  • [37] Physical activities and breast cancer: a Mendelian randomization study
    Ding, Lishan
    Chen, Qingliang
    Liang, Hao
    Shen, Meng
    Zheng, Ming
    Li, Zhaojun
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (06) : 1957 - 1967
  • [38] Insights into Modifiable Risk Factors of Infertility: A Mendelian Randomization Study
    Xu, Wentao
    You, Yueyuan
    Yu, Tianqi
    Li, Jing
    NUTRIENTS, 2022, 14 (19)
  • [39] The impact of lipidome on breast cancer: a Mendelian randomization study
    Cao, Yuchen
    Ai, Meichen
    Liu, Chunjun
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [40] Insights into Causal Cardiovascular Risk Factors from Mendelian Randomization
    Schooling, C. M.
    Zhao, J. V.
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (02) : 67 - 76